Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Income from Continuing Operations: 2023-2025

Historic Income from Continuing Operations for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to -$6.4 million.

  • Incannex Healthcare's Income from Continuing Operations fell 18.21% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.9 million, marking a year-over-year decrease of 107.03%. This contributed to the annual value of -$46.9 million for FY2025, which is 154.00% down from last year.
  • According to the latest figures from Q3 2025, Incannex Healthcare's Income from Continuing Operations is -$6.4 million, which was up 79.73% from -$31.6 million recorded in Q2 2025.
  • Incannex Healthcare's Income from Continuing Operations' 5-year high stood at -$726,000 during Q3 2023, with a 5-year trough of -$31.6 million in Q2 2025.
  • Over the past 3 years, Incannex Healthcare's median Income from Continuing Operations value was -$5.9 million (recorded in 2024), while the average stood at -$8.0 million.
  • Per our database at Business Quant, Incannex Healthcare's Income from Continuing Operations slumped by 646.56% in 2024 and then skyrocketed by 34.21% in 2025.
  • Over the past 3 years, Incannex Healthcare's Income from Continuing Operations (Quarterly) stood at -$5.2 million in 2023, then declined by 12.46% to -$5.9 million in 2024, then fell by 18.21% to -$6.4 million in 2025.
  • Its Income from Continuing Operations stands at -$6.4 million for Q3 2025, versus -$31.6 million for Q2 2025 and -$4.0 million for Q1 2025.